The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery.
作者信息
Osataphan Soravis, Patell Rushad, Babuta Mrigya, Rosovsky Rachel P, Hisada Yohei, Edmiston Charly, Elavalakanar Pavania, Pfeffer Michael A, Bregar Amy, Ramos Amanda, Garrett Leslie, Ren Siyang, Neuberg Donna, Szabo Gyongyi, Flaumenhaft Robert, Mackman Nigel, Shea Meghan, Zwicker Jeffrey I
机构信息
Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
出版信息
Blood Adv. 2025 Sep 9;9(17):4472-4476. doi: 10.1182/bloodadvances.2025016107.
Abstract
摘要
Zotero 插件